189 related articles for article (PubMed ID: 27245461)
1. Vascular Smooth Muscle-Specific EP4 Receptor Deletion in Mice Exacerbates Angiotensin II-Induced Renal Injury.
Thibodeau JF; Holterman CE; He Y; Carter A; Cron GO; Boisvert NC; Abd-Elrahman KS; Hsu KJ; Ferguson SS; Kennedy CR
Antioxid Redox Signal; 2016 Oct; 25(12):642-656. PubMed ID: 27245461
[TBL] [Abstract][Full Text] [Related]
2. VSMC-specific EP4 deletion exacerbates angiotensin II-induced aortic dissection by increasing vascular inflammation and blood pressure.
Xu H; Du S; Fang B; Li C; Jia X; Zheng S; Wang S; Li Q; Su W; Wang N; Zheng F; Chen L; Zhang X; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8457-8462. PubMed ID: 30948641
[TBL] [Abstract][Full Text] [Related]
3. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE
Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139
[TBL] [Abstract][Full Text] [Related]
4. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
[TBL] [Abstract][Full Text] [Related]
5. Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress.
Jia Z; Guo X; Zhang H; Wang MH; Dong Z; Yang T
Hypertension; 2008 Nov; 52(5):952-9. PubMed ID: 18824665
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of human EP4 receptor in vascular smooth muscle cells attenuates angiotensin II-induced hypertension in mice].
Xu H; Wang SL; Bao CZ; Ye L; Guan YF; Zhang XY
Sheng Li Xue Bao; 2021 Aug; 73(4):597-605. PubMed ID: 34405216
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
[TBL] [Abstract][Full Text] [Related]
8. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101
[TBL] [Abstract][Full Text] [Related]
9. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6.
Mohamed R; Jayakumar C; Ramesh G
Lab Invest; 2013 Aug; 93(8):933-45. PubMed ID: 23817085
[TBL] [Abstract][Full Text] [Related]
11. A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.
Das S; Zhang E; Senapati P; Amaram V; Reddy MA; Stapleton K; Leung A; Lanting L; Wang M; Chen Z; Kato M; Oh HJ; Guo Q; Zhang X; Zhang B; Zhang H; Zhao Q; Wang W; Wu Y; Natarajan R
Circ Res; 2018 Dec; 123(12):1298-1312. PubMed ID: 30566058
[TBL] [Abstract][Full Text] [Related]
12. Sulfur Dioxide Inhibits Extracellular Signal-regulated Kinase Signaling to Attenuate Vascular Smooth Muscle Cell Proliferation in Angiotensin II-induced Hypertensive Mice.
Wu HJ; Huang YQ; Chen QH; Tian XY; Liu J; Tang CS; Jin HF; Du JB
Chin Med J (Engl); 2016 Sep; 129(18):2226-32. PubMed ID: 27625096
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney.
Srivastava T; Alon US; Cudmore PA; Tarakji B; Kats A; Garola RE; Duncan RS; McCarthy ET; Sharma R; Johnson ML; Bonewald LF; El-Meanawy A; Savin VJ; Sharma M
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1323-33. PubMed ID: 25234310
[TBL] [Abstract][Full Text] [Related]
14. Cell-Specific Actions of the Prostaglandin E-Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages.
Yang T; Song C; Ralph DL; Andrews P; Sparks MA; Koller BH; McDonough AA; Coffman TM
J Am Heart Assoc; 2022 Oct; 11(19):e026581. PubMed ID: 36172956
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.
Forrester SJ; Elliott KJ; Kawai T; Obama T; Boyer MJ; Preston KJ; Yan Z; Eguchi S; Rizzo V
Hypertension; 2017 Jan; 69(1):79-86. PubMed ID: 27895190
[TBL] [Abstract][Full Text] [Related]
16. mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress.
Avendaño MS; García-Redondo AB; Zalba G; González-Amor M; Aguado A; Martínez-Revelles S; Beltrán LM; Camacho M; Cachofeiro V; Alonso MJ; Salaices M; Briones AM
Hypertension; 2018 Aug; 72(2):492-502. PubMed ID: 29891646
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors.
Eskildsen MP; Hansen PB; Stubbe J; Toft A; Walter S; Marcussen N; Rasmussen LM; Vanhoutte PM; Jensen BL
Hypertension; 2014 Sep; 64(3):551-6. PubMed ID: 24914192
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol prevents angiotensin II-induced hypertrophy of vascular smooth muscle cells through the transactivation of growth factor receptors.
Hossain E; Anand-Srivastava MB
Can J Physiol Pharmacol; 2017 Aug; 95(8):945-953. PubMed ID: 28704617
[TBL] [Abstract][Full Text] [Related]
19. Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E
Hong YA; Yang KJ; Jung SY; Park KC; Choi H; Oh JM; Lee SJ; Chang YK; Park CW; Yang CW; Kim SY; Hwang HS
Oxid Med Cell Longev; 2017; 2017():5031926. PubMed ID: 28465762
[TBL] [Abstract][Full Text] [Related]
20. Binding of EBP50 to Nox organizing subunit p47phox is pivotal to cellular reactive species generation and altered vascular phenotype.
Al Ghouleh I; Meijles DN; Mutchler S; Zhang Q; Sahoo S; Gorelova A; Henrich Amaral J; Rodríguez AI; Mamonova T; Song GJ; Bisello A; Friedman PA; Cifuentes-Pagano ME; Pagano PJ
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5308-17. PubMed ID: 27540115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
